Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

A Phase I/II Study of the CXCR2 Inhibitor, AZD5069, in Combination with Durvalumab, in Patients (pts) with Advanced Hepatocellular Carcinoma (HCC).

T. R. Jeffry Evans,Bristi Basu,Richard Hubner,Yuk Ting Ma,Tim Meyer,Daniel H. Palmer,David J. James Pinato,Elizabeth Ruth Plummer,Paul J. Ross,Adel Samson,Debashis Sarker,Timothy Kendall,Christopher Bellamy,Helen L. Reeves, Fiona Thomson,Claire A. Lawless,Jamie Stobo,Owen J. Sansom,Derek A. Mann,Thomas G. Bird

JOURNAL OF CLINICAL ONCOLOGY（2023）

Cited 2|Views32

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined